现代化帕金森病的分期使用数字卫生技术
John Michael Templeton1,2, Christian Poellabauer3, Sandra Schneider4
1Bellini College of Artificial Intelligence, Cybersecurity, and Computing, University of South Florida, Tampa, FL, United States.
Journal of medical Internet research
|April 4, 2025
概括
帕金森病 (PD) 的评估需要客观,全面的方法. 本文提出了一种使用数字健康技术的新分期方案,用于个性化,针对PD患者神经认知的症状特异性监测.
科学领域:
- 神经科学是一个神经科学.
- 数字健康技术 数字健康技术
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 的评估是复杂的,依赖于主观的措施.
- 目前的方法缺乏对PD影响的所有神经认知领域的全面客观评估.
- 现有的分阶段方案 (例如,霍恩和雅尔尺度) 需要加强,以便更广泛地应用.
研究的目的:
- 突出数字健康技术在PD分类和监测中的日益重要的作用.
- 提出一个新的PD分期方案的基础.
- 整合PD影响的所有神经认知功能的客观,特征性评估.
主要方法:
- 审查目前对帕金森病 (PD) 的主观评估工具.
- 突出数字健康技术 (智能手机,可穿戴设备) 在PD中的应用.
- 开发一个新的阶段化方案基础,将已建立的尺度与数字健康能力相结合.
主要成果:
- 数字健康技术为PD评估提供客观数据收集.
- 提出了一个新的分阶段方案基础,将传统尺度与数字工具相结合.
- 拟议的系统旨在针对特定症状进行客观的神经认知评估.
结论:
- 用客观的数字工具对PD评估进行现代化至关重要.
- 这种方法支持个性化医疗和改善PD患者的生活质量.
- 拟议的分期系统基础使全面的神经认知监测成为可能.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
3.6K
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
相关概念视频
Parkinson's Disease: Treatment
163
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
163
Parkinson's Disease: Overview
360
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
360
